Ticker Symbol: XNCR
Xencor Inc
$37.63 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001326732
Company Profile
Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 20 candidates engineered with Xencor's XmAb® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 111 W Lemon Ave
Website: www.xencor.com
CEO: Bassil Dahiyat
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $19.60
Change:
$0.12
(
0.62%)
Days Range: $19.16 - $19.80
Beta: 0.79
52wk. High: $38.20
52wk. Low: $18.17
Ytd. Change -24.58%
50 Day Moving Average: $20.04
200 Day Moving Average: $24.27
Shares Outstanding: 60613236
Valuation
Market Cap: 118.8B
PE Ratio: -9.12
EPS (TTM): -2.15
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A